New study to see if suctioning out blood clots beats standard care for deep vein thrombosis
NCT ID NCT07573618
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two treatments for acute deep vein thrombosis (DVT) in the leg. Half of the 104 participants will receive standard blood-thinning medication alone, while the other half will also undergo a procedure to suction out the clot, sometimes with balloon dilation or a stent. Researchers will follow patients for 24 months to see which group has fewer complications like clot recurrence, lung clots, or long-term leg damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- thrombus aspiration procedure
- What this could lead to
- If successful, this could offer a more effective way to treat deep vein thrombosis and reduce long-term complications like post-thrombotic syndrome.
- What could go wrong
- This is a relatively small trial (104 people) and has not started recruiting yet. The procedure carries risks like bleeding or vessel damage, and it may not prove better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEEP VEIN THROMBOSIS OF LOWER LIMB are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.